Literature DB >> 26213642

Vascular Dementia.

Alberto R Ramos1, Salim I Dib1, Clinton B Wright2.   

Abstract

The purpose of this review is to highlight existing literature on the epidemiology, pathophysiology, and novel risk factors for vascular dementia. We further examine the evidence linking chronic brain hypoperfusion induced by a variety of cardiovascular diseases to the development of vascular dementia. In the elderly, in whom cerebral perfusion is diminished by the aging process, additional reduction in cerebral blood flow stemming from exposure to potentially modifiable vascular risk factors increases the probability of developing vascular dementia. Finally, we discuss the association between obstructive sleep apnea, an underrecognized risk factor for stroke, and vascular dementia. Obstructive sleep apnea is linked to cerebrovascular disease through many intermediary vascular risk factors and may directly cause cerebrovascular damage through microvacular disease. Insight into how cardiovascular risk factors induce vascular dementia offers an enhanced understanding of the multifactorial pathophysiology by this disorder and ways of preventing and managing the cerebrovascular precursors of vascular dementia. Many vital questions about the relation of obstructive sleep apnea with stroke and vascular dementia are still unanswered and await future well-designed studies.

Entities:  

Keywords:  Vascular dementia; brain imaging; cerebral hypoperfusion; elderly; obstructive sleep apnea; sleep; stroke; vascular risk factors

Year:  2013        PMID: 26213642      PMCID: PMC4513364          DOI: 10.1007/s13670-013-0054-5

Source DB:  PubMed          Journal:  Curr Transl Geriatr Exp Gerontol Rep        ISSN: 2162-4941


  83 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study.

Authors:  Susan Redline; Gayane Yenokyan; Daniel J Gottlieb; Eyal Shahar; George T O'Connor; Helaine E Resnick; Marie Diener-West; Mark H Sanders; Philip A Wolf; Estella M Geraghty; Tauqeer Ali; Michael Lebowitz; Naresh M Punjabi
Journal:  Am J Respir Crit Care Med       Date:  2010-03-25       Impact factor: 21.405

3.  Cognitive impairment in lacunar strokes: the SPS3 trial.

Authors:  Claudia Jacova; Lesly A Pearce; Raymond Costello; Leslie A McClure; Stephen L Holliday; Robert G Hart; Oscar R Benavente
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

4.  Sleep duration, sleep quality and cardiovascular disease mortality among the elderly: a population-based cohort study.

Authors:  Etsuji Suzuki; Takashi Yorifuji; Kazumune Ueshima; Soshi Takao; Masumi Sugiyama; Toshiki Ohta; Kazuko Ishikawa-Takata; Hiroyuki Doi
Journal:  Prev Med       Date:  2009-06-30       Impact factor: 4.018

Review 5.  Sleep-related breathing and sleep-wake disturbances in ischemic stroke.

Authors:  Dirk M Hermann; Claudio L Bassetti
Journal:  Neurology       Date:  2009-10-20       Impact factor: 9.910

Review 6.  Sleep disorders and stroke.

Authors:  Douglas M Wallace; Alberto R Ramos; Tatjana Rundek
Journal:  Int J Stroke       Date:  2012-02-15       Impact factor: 5.266

7.  The metabolic syndrome and cognitive performance: the Northern Manhattan Study.

Authors:  Julio R Vieira; Mitchell S V Elkind; Yeseon Park Moon; Tatjana Rundek; Bernadette Boden-Albala; Myunghee C Paik; Ralph L Sacco; Clinton B Wright
Journal:  Neuroepidemiology       Date:  2011-10-15       Impact factor: 3.282

8.  Dementia prevention: current epidemiological evidence and future perspective.

Authors:  Francesca Mangialasche; Miia Kivipelto; Alina Solomon; Laura Fratiglioni
Journal:  Alzheimers Res Ther       Date:  2012-02-13       Impact factor: 6.982

Review 9.  Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans.

Authors:  Raj N Kalaria
Journal:  Stroke       Date:  2012-08-09       Impact factor: 7.914

10.  Blood brain barrier breakdown as the starting point of cerebral small vessel disease? - New insights from a rat model.

Authors:  Stefanie Schreiber; Celine Zoe Bueche; Cornelia Garz; Holger Braun
Journal:  Exp Transl Stroke Med       Date:  2013-03-14
View more
  6 in total

1.  Sleep and neurocognitive decline in the Hispanic Community Health Study/Study of Latinos.

Authors:  Alberto R Ramos; Wassim Tarraf; Benson Wu; Susan Redline; Jianwen Cai; Martha L Daviglus; Linda Gallo; Yasmin Mossavar-Rahmani; Krista M Perreira; Phyllis Zee; Donglin Zeng; Hector M Gonzalez
Journal:  Alzheimers Dement       Date:  2020-01-06       Impact factor: 21.566

2.  Uvulopalatopharyngoplasty May Reduce the Incidence of Dementia Caused by Obstructive Sleep Apnea: National Insurance Service Survey 2007-2014.

Authors:  Jae Hoon Cho; Jeffrey D Suh; Kyung-Do Han; Jin-Hyung Jung; Heung Man Lee
Journal:  J Clin Sleep Med       Date:  2018-10-15       Impact factor: 4.062

Review 3.  Obstructive sleep apnea and stroke: links to health disparities.

Authors:  Alberto R Ramos; Azizi Seixas; Salim I Dib
Journal:  Sleep Health       Date:  2015-10-21

4.  Diabetes in a Large Dementia Cohort: Clinical Characteristics and Treatment From the Swedish Dementia Registry.

Authors:  Juraj Secnik; Pavla Cermakova; Seyed-Mohammad Fereshtehnejad; Pontus Dannberg; Kristina Johnell; Johan Fastbom; Bengt Winblad; Maria Eriksdotter; Dorota Religa
Journal:  Diabetes Care       Date:  2017-06-27       Impact factor: 19.112

5.  Gastrodin Ameliorates Cognitive Dysfunction in Vascular Dementia Rats by Suppressing Ferroptosis via the Regulation of the Nrf2/Keap1-GPx4 Signaling Pathway.

Authors:  Yue Li; Erdong Zhang; Hong Yang; Yongxin Chen; Ling Tao; Yini Xu; Tingting Chen; Xiangchun Shen
Journal:  Molecules       Date:  2022-09-24       Impact factor: 4.927

6.  Rannasangpei Is a Therapeutic Agent in the Treatment of Vascular Dementia.

Authors:  Peng Wu; Yuandai Luo; Lifang Zhen; Xianda Hu; Ying Shang; Yinuo Liao; Huiyuan Xue; Fukai Huang; Wei Xiao
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-17       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.